Develops infertility treatments and diagnostic devices for women's health.
Jun 2026Revenue $2.30M/yrExpenses $19.9M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Femasys be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $2.30M and expenses $19.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.29M | $19.9M | −$17.6M |
| Dec 2024 | $1.63M | $19.4M | −$17.8M |
| Dec 2023 | $1.07M | $15.6M | −$14.5M |
| Dec 2022 | $1.21M | $12.8M | −$11.6M |
| Dec 2021 | $1.18M | $9.52M | −$8.34M |
| Dec 2020 | $1.04M | $7.97M | −$6.93M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.